http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H1179978-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b55c349b43c3ecba4977fd52cc8f8c67 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 1997-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d97fa39b3f80ff77ecd06c212385aaf7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d23f19226b4aebcaaf73bdcb83d49b9b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93f6390ca96f686c4d1459fb65b417a5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_895c70dcf9441c3d98a5233d91f2bbeb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fabb9f5bd79eedbd3349a175fb7f5ec4 |
| publicationDate | 1999-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-H1179978-A |
| titleOfInvention | Transdermal formulation |
| abstract | (57) Abstract: An acrylic copolymer pressure-sensitive adhesive comprising a functional monomer as an essential component and an azo compound such as azo-bis-isobutyronitrile as a polymerization initiator is contained in an adhesive. -Contains mercaptobenzimidazole and / or propyl gallate and a transdermally absorbable drug such as azelastine. This drug-containing adhesive layer is formed on at least one surface of the support to obtain a transdermal absorption preparation. [Effect] The coloring phenomenon that occurs when a transdermally absorbable drug is incorporated into an acrylic copolymer pressure-sensitive adhesive is prevented. Therefore, it suppresses the coloring phenomenon due to the interaction between the transdermally absorbable drug and various trace components in the acrylic copolymer adhesive or the coloring enhancement phenomenon during the storage period, and has a stable and acceptable appearance in the preparation. It becomes a transdermal preparation. Further, the stability of the transdermally absorbable drug content is excellent. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2011190203-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008101029-A |
| priorityDate | 1997-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 96.